Markus Löbrich
Impact in
- Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment
- Molecular Biology top 0.5%
- DNA Repair Mechanisms
- Genomics and Chromatin Dynamics
- CRISPR and Genetic Engineering
Papers in
-
- Carcinogens and Genotoxicity Assessment 36
- Oncology 35
- Cancer-related Molecular Pathways 16
- PARP inhibition in cancer therapy 16
- Co-authors
- Penny A. JeggoKai RothkammNicole RiefAaron A. GoodarziAtsushi ShibataOlivia BartonDorothee DeckbarMartin Kühne
- Journals
- Radiation Research (7 papers)Molecular Cell (7 papers)DNA repair (6 papers)Proceedings of the National Academy of Sciences (6 papers)Nucleic Acids Research (4 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Markus Löbrich
90 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 3.3k
- Molecular Biology 9.7k
- Oncology 3.6k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Pulmonary and Respiratory Medicine 2.1k
Countries citing papers authored by Markus Löbrich
This map shows the geographic impact of Markus Löbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Löbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Löbrich more than expected).
Fields of papers citing papers by Markus Löbrich
This network shows the impact of papers produced by Markus Löbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Löbrich. The network helps show where Markus Löbrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Löbrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 67 | |
| 3 | 2020 | 5 | |
| 4 | 2018 | 109 | |
| 5 | 2014 | 148 | |
| 6 | 2011 | 157 | |
| 7 | 2010 | 57 | |
| 8 | 2010 | 238 | |
| 9 | 2009 | 75 | |
| 10 | 2009 | 420 | |
| 11 | 2007 | 45 | |
| 12 | 2007 | 474 | |
| 13 | 2005 | 59 | |
| 14 | 2005 | 83 | |
| 15 | ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation Hit paper breakdown → | 2004 | 811 |
| 16 | A Pathway of Double-Strand Break Rejoining Dependent upon ATM, Artemis, and Proteins Locating to γ-H2AX Foci Hit paper breakdown → | 2004 | 683 |
| 17 | 2002 | 40 | |
| 18 | 2000 | 18 | |
| 19 | 1994 | 39 | |
| 20 | 1993 | 25 |
About Markus Löbrich
Markus Löbrich is a scholar working on Cancer Research, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 11.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (76 papers), Carcinogens and Genotoxicity Assessment (36 papers), Cancer-related Molecular Pathways (16 papers), PARP inhibition in cancer therapy (16 papers), Radiation Therapy and Dosimetry (15 papers), Plant Genetic and Mutation Studies (12 papers), Effects of Radiation Exposure (11 papers) and Genomics and Chromatin Dynamics (10 papers). The work is most often cited by research in Cancer Research (3.3k citations), Molecular Biology (9.7k citations), Oncology (3.6k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Markus Löbrich has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Penny A. Jeggo, Kai Rothkamm, Nicole Rief, Aaron A. Goodarzi, Atsushi Shibata, Olivia Barton, Dorothee Deckbar, Martin Kühne, Andrea Krempler and Sandro Conrad. Their work appears in journals such as Radiation Research, Molecular Cell, DNA repair, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.